GB1533243A - Tablet formulation - Google Patents
Tablet formulationInfo
- Publication number
- GB1533243A GB1533243A GB6174/75A GB617475A GB1533243A GB 1533243 A GB1533243 A GB 1533243A GB 6174/75 A GB6174/75 A GB 6174/75A GB 617475 A GB617475 A GB 617475A GB 1533243 A GB1533243 A GB 1533243A
- Authority
- GB
- United Kingdom
- Prior art keywords
- tablet formulation
- sulphonamide
- feb
- disintegrating agent
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Abstract
1533243 Tablets containing sulphonamides WELLCOME FOUNDATION Ltd 13 Feb 1976 [13 Feb 1975] 6174/75 Heading A5B A tablet comprises from 80-98% (w/w) of a sulphonamide, a disintegrating agent and a granulating agent, the total amount of both agents being from 2-20% (w/w), wherein the particle size (as defined) of the sulphonamide is less than 40Ám and the disintegrating agent has a swelling capacity (as defined) greater than 5 ml/g.
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB6174/75A GB1533243A (en) | 1975-02-13 | 1975-02-13 | Tablet formulation |
JP51014332A JPS51106711A (en) | 1975-02-13 | 1976-02-12 | |
CA245,882A CA1052267A (en) | 1975-02-13 | 1976-02-12 | Table formulation |
FI760340A FI760340A (en) | 1975-02-13 | 1976-02-12 | |
DK57376*#A DK57376A (en) | 1975-02-13 | 1976-02-12 | THE SULPHONE CABLE |
HU76WE00000534A HU171201B (en) | 1975-02-13 | 1976-02-12 | Process for preparing pharmaceutical preparations containing sulphonamides |
BE164281A BE838507A (en) | 1975-02-13 | 1976-02-12 | PHARMACEUTICAL TABLETS |
FR7603829A FR2300550A1 (en) | 1975-02-13 | 1976-02-12 | ANTIMICROBIAL DRUG |
IE272/76A IE42952B1 (en) | 1975-02-13 | 1976-02-12 | Tablet formulation |
SE7601564A SE7601564L (en) | 1975-02-13 | 1976-02-12 | WAY TO MAKE TABLETS |
NL7601423A NL7601423A (en) | 1975-02-13 | 1976-02-12 | PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION. |
DE19762605656 DE2605656A1 (en) | 1975-02-13 | 1976-02-12 | PHARMACEUTICAL PREPARATIONS IN TABLET FORM |
IL7649024A IL49024A (en) | 1975-02-13 | 1976-02-12 | Sulphonamide tablet formulations |
ZA760829A ZA76829B (en) | 1975-02-13 | 1976-02-12 | Tablet formulation |
AU11108/76A AU495948B2 (en) | 1975-02-13 | 1976-02-13 | Tablet formulation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB6174/75A GB1533243A (en) | 1975-02-13 | 1975-02-13 | Tablet formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1533243A true GB1533243A (en) | 1978-11-22 |
Family
ID=9809772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB6174/75A Expired GB1533243A (en) | 1975-02-13 | 1975-02-13 | Tablet formulation |
Country Status (14)
Country | Link |
---|---|
JP (1) | JPS51106711A (en) |
BE (1) | BE838507A (en) |
CA (1) | CA1052267A (en) |
DE (1) | DE2605656A1 (en) |
DK (1) | DK57376A (en) |
FI (1) | FI760340A (en) |
FR (1) | FR2300550A1 (en) |
GB (1) | GB1533243A (en) |
HU (1) | HU171201B (en) |
IE (1) | IE42952B1 (en) |
IL (1) | IL49024A (en) |
NL (1) | NL7601423A (en) |
SE (1) | SE7601564L (en) |
ZA (1) | ZA76829B (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4524060A (en) * | 1981-05-21 | 1985-06-18 | John Wyeth & Brother Limited | Slow release pharmaceutical composition |
US5556639A (en) * | 1991-01-30 | 1996-09-17 | Glaxo Wellcome Inc. | Water-dispersible tablets |
US5629016A (en) * | 1991-01-30 | 1997-05-13 | Glaxo Wellcome Inc. | Water-dispersible tablets |
US5698226A (en) * | 1993-07-13 | 1997-12-16 | Glaxo Wellcome Inc. | Water-dispersible tablets |
US8173161B2 (en) | 2002-12-04 | 2012-05-08 | Mcneil-Ppc, Inc. | Method of administering a pharmaceutical active ingredient |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1601833A (en) * | 1978-02-06 | 1981-11-04 | Wellcome Found | Antacid formulation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1460302A (en) * | 1973-05-23 | 1977-01-06 | Wellcome Found | Tablet formulation |
GB1499672A (en) * | 1974-02-14 | 1978-02-01 | Wellcome Found | Tablet formulation |
-
1975
- 1975-02-13 GB GB6174/75A patent/GB1533243A/en not_active Expired
-
1976
- 1976-02-12 IE IE272/76A patent/IE42952B1/en unknown
- 1976-02-12 SE SE7601564A patent/SE7601564L/en unknown
- 1976-02-12 DK DK57376*#A patent/DK57376A/en unknown
- 1976-02-12 BE BE164281A patent/BE838507A/en unknown
- 1976-02-12 CA CA245,882A patent/CA1052267A/en not_active Expired
- 1976-02-12 HU HU76WE00000534A patent/HU171201B/en unknown
- 1976-02-12 FR FR7603829A patent/FR2300550A1/en active Granted
- 1976-02-12 JP JP51014332A patent/JPS51106711A/ja active Pending
- 1976-02-12 ZA ZA760829A patent/ZA76829B/en unknown
- 1976-02-12 FI FI760340A patent/FI760340A/fi not_active Application Discontinuation
- 1976-02-12 IL IL7649024A patent/IL49024A/en unknown
- 1976-02-12 NL NL7601423A patent/NL7601423A/en not_active Application Discontinuation
- 1976-02-12 DE DE19762605656 patent/DE2605656A1/en not_active Withdrawn
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4524060A (en) * | 1981-05-21 | 1985-06-18 | John Wyeth & Brother Limited | Slow release pharmaceutical composition |
US5556639A (en) * | 1991-01-30 | 1996-09-17 | Glaxo Wellcome Inc. | Water-dispersible tablets |
US5629016A (en) * | 1991-01-30 | 1997-05-13 | Glaxo Wellcome Inc. | Water-dispersible tablets |
US5660860A (en) * | 1991-01-30 | 1997-08-26 | Glaxo Wellcome Inc. | Water-dispersible tablets |
US5698226A (en) * | 1993-07-13 | 1997-12-16 | Glaxo Wellcome Inc. | Water-dispersible tablets |
US8173161B2 (en) | 2002-12-04 | 2012-05-08 | Mcneil-Ppc, Inc. | Method of administering a pharmaceutical active ingredient |
Also Published As
Publication number | Publication date |
---|---|
HU171201B (en) | 1977-11-28 |
ZA76829B (en) | 1977-09-28 |
FI760340A (en) | 1976-08-14 |
DE2605656A1 (en) | 1976-08-26 |
JPS51106711A (en) | 1976-09-21 |
DK57376A (en) | 1976-08-14 |
FR2300550B1 (en) | 1979-09-21 |
IL49024A (en) | 1979-03-12 |
BE838507A (en) | 1976-08-12 |
NL7601423A (en) | 1976-08-17 |
IE42952L (en) | 1976-08-13 |
SE7601564L (en) | 1976-08-16 |
CA1052267A (en) | 1979-04-10 |
AU1110876A (en) | 1977-08-18 |
IE42952B1 (en) | 1980-11-19 |
FR2300550A1 (en) | 1976-09-10 |
IL49024A0 (en) | 1976-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8308698A1 (en) | Topical pharmaceutical compositions | |
AU576197B2 (en) | Particulate n-acetyl-p-aminophenol composition | |
GB1341514A (en) | ||
DK154537C (en) | QUICK-DISINTEGRATING COMPRESSED PHARMACEUTICAL PREPARATIONS | |
IE790209L (en) | Antacid formulation | |
GB1390803A (en) | Medicinal tampons and compositions containing lactulose | |
GB1533243A (en) | Tablet formulation | |
GB1492687A (en) | Water-soluble lubricant in tabletting compositions | |
GB1355985A (en) | Solid slow release preparation of prolonged action | |
ES434688A1 (en) | Tablet formulation | |
GB1445983A (en) | Pharmaceutical formulations | |
GB1460302A (en) | Tablet formulation | |
GB1153324A (en) | Sustained Release Tablets | |
GB1113492A (en) | Chewable tablets comprising a penicillin antibiotic | |
GB1341376A (en) | Pharmaceutical compositions comprising 4-methyl-5-2-aminoethyl imidazole | |
GB1465771A (en) | Pharmaceutical composition and use thereofd | |
GB1287433A (en) | Pharmaceutical compositions | |
GB889377A (en) | Tapeworm control agents | |
GB1233150A (en) | ||
USD221004S (en) | Combined swivel base and index for desk telephones | |
GB1509778A (en) | Pharmaceutical composition and dosage units thereof | |
JPS5344617A (en) | Drug composition | |
AU476756B2 (en) | PHARMACOLOGICALLY ACTIVE 4, 8-DIMETHOXY-FURO-(3',2'-F) BENZOXAZOL-2-yl ACETHYDROXAMIC ACID | |
ES383340A1 (en) | P-(acetoacetamidoalkyl)benzenesulfonamide derivatives | |
GB1491550A (en) | Pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
PCNP | Patent ceased through non-payment of renewal fee |